Bosh sahifaAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Yopilish kursi
0,080 $
Kunlik diapazon
0,071 $ - 0,080 $
Yillik diapazon
0,025 $ - 0,36 $
Bozor kapitalizatsiyasi
5,35 mln USD
Oʻrtacha hajm
482,80 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
.INX
0,15%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 45,00 ming | -30,77% |
Joriy xarajat | 5,89 mln | -58,08% |
Sof foyda | -5,97 mln | 52,55% |
Sof foyda marjasi | -13,26 ming | 31,46% |
Har bir ulushga tushum | -0,10 | 64,56% |
EBITDA | -5,79 mln | 58,48% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 3,98 mln | -69,57% |
Jami aktivlari | 8,61 mln | -55,59% |
Jami passivlari | 9,93 mln | 8,56% |
Umumiy kapital | -1,32 mln | — |
Tarqatilgan aksiyalar | 72,29 mln | — |
Narxi/balansdagi bahosi | -3,98 | — |
Aktivlardan daromad | -131,89% | — |
Kapitaldan daromad | -369,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -5,97 mln | 52,55% |
Operatsiyalardan naqd pul | -3,96 mln | 59,47% |
Sarmoyadan naqd pul | 3,70 mln | 1 830,84% |
Moliyadan naqd pul | 1,04 mln | 605,44% |
Naqd pulning sof oʻzgarishi | 786,00 ming | 108,00% |
Boʻsh pul | -3,65 mln | 40,05% |
Haqida
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Tashkil etilgan
1966
Sayt
Xodimlar soni
22